基于PT-INR和年龄的模型是评估SARS-CoV-2感染患者死亡风险的有希望的预测指标
Yongjie Xu1,2,3,4,5,6, Minjie Tang1,2,3,4,5,6, Zhaopei Guo1,2,3,4,5
1Department of Laboratory Medicine, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Frontiers in cellular and infection microbiology
|April 18, 2025
概括
预测COVID-19患者的结果至关重要. 一种使用肺炎,年龄和PT-INR的新型诺摩图模型有效地识别出预后不佳的患者,有助于临床治疗策略.
科学领域:
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
- 医疗信息学 医疗信息学
背景情况:
- 冠状病毒疾病2019 (COVID-19) 流行病需要早期预后评估.
- 关于预测COVID-19严重程度的综合多标志物方法的研究有限.
- 在严重的COVID-19病例中,呼吸困难和缺氧是关键问题.
研究的目的:
- 系统地比较住院COVID-19患者在入院时的临床特征.
- 开发和验证用于预测COVID-19患者预后的诺莫格拉姆模型.
- 确定用于评估疾病严重程度和指导治疗的关键临床标志物.
主要方法:
- 来自大量住院COVID-19患者的临床数据的分析.
- 在入院时对临床特征进行系统比较.
- 开发包含肺炎,年龄和PT-INR用于预后预测的诺莫格拉姆模型.
主要成果:
- 肺炎,老年和较高的PT-INR与所有COVID-19患者的预后不佳有关.
- 包括肺炎,年龄和PT-INR在内的名录图准确地预测了整体队列中的预后.
- 一个带有年龄和PT-INR的名图有效预测了肺炎患者的预后.
结论:
- 已建立的预后预测模型有助于及时识别高风险的COVID-19患者.
- 这些模型可以促进改善临床治疗策略.
- 多标志物名录为管理COVID-19患者提供了一种有价值的工具.
相关概念视频
Actuarial Approach
39
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
39
Kaplan-Meier Approach
55
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
55
Comparing the Survival Analysis of Two or More Groups
85
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
85
Cancer Survival Analysis
298
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
298
Steps in Outbreak Investigation
90
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
90
Assumptions of Survival Analysis
57
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
57


